Full Name
Dr. Stephanie Gaillard
Job Title
Assistant Professor of Oncology, Assistant Professor of Gynecology and Obstetrics, Director of Gynecologic Cancer Trials
Company
Johns Hopkins School of Medicine
Speaker Bio
Stéphanie Gaillard, M.D., Ph.D. is a medical oncologist who specializes in the treatment of gynecologic malignancies, including ovarian, endometrial, and cervical cancers. She is an assistant professor of Oncology and Gynecology/Obstetrics and is the Director of Gynecologic Cancer Trials at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
Dr. Gaillard earned an M.D. and a Ph.D. in cancer biology from Duke University. She completed residency training in Internal Medicine and fellowship training in Medical Oncology at the Johns Hopkins School of Medicine. Prior to joining the faculty at Johns Hopkins, she was a faculty member at Duke University Medical Center. She is board certified in Medical Oncology.
Dr. Gaillard’s research focuses on the development of clinical trials aimed at improving outcomes using promising new biologic, targeted, and immune therapies in addition to standard treatment regimens. Her translational research program focuses on understanding mechanisms of resistance to therapy and the immune environment associated with gynecologic cancers. In addition, Dr. Gaillard serves as the Co-Chair of the NRG Oncology Phase I sub-committee.
Dr. Gaillard has been honored with several awards in her career, including the Liz Tilberis Early Career Award from the Ovarian Cancer Research Fund, the Young Investigator Award from the Conquer Cancer Foundation. She was a NIH BIRCWH (Building Interdisciplinary Research Careers in Women's Health) Scholar and is a 2019 GOG Foundation Scholar Investigator Award recipient. She is the principal or co-author of numerous publications and book chapters and has traveled nationally and internationally to present her research.
Dr. Gaillard earned an M.D. and a Ph.D. in cancer biology from Duke University. She completed residency training in Internal Medicine and fellowship training in Medical Oncology at the Johns Hopkins School of Medicine. Prior to joining the faculty at Johns Hopkins, she was a faculty member at Duke University Medical Center. She is board certified in Medical Oncology.
Dr. Gaillard’s research focuses on the development of clinical trials aimed at improving outcomes using promising new biologic, targeted, and immune therapies in addition to standard treatment regimens. Her translational research program focuses on understanding mechanisms of resistance to therapy and the immune environment associated with gynecologic cancers. In addition, Dr. Gaillard serves as the Co-Chair of the NRG Oncology Phase I sub-committee.
Dr. Gaillard has been honored with several awards in her career, including the Liz Tilberis Early Career Award from the Ovarian Cancer Research Fund, the Young Investigator Award from the Conquer Cancer Foundation. She was a NIH BIRCWH (Building Interdisciplinary Research Careers in Women's Health) Scholar and is a 2019 GOG Foundation Scholar Investigator Award recipient. She is the principal or co-author of numerous publications and book chapters and has traveled nationally and internationally to present her research.
Speaking At
